Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Zynex ( (ZYXIQ) ) just unveiled an announcement.
On December 15, 2025, Zynex, Inc. and certain subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Southern District of Texas, and on December 17, 2025 the company obtained interim court approval for a $22.3 million debtor-in-possession term loan structured in three draws to support operations during the restructuring. On January 14, 2026, Zynex amended its DIP credit agreement to extend milestones tied to final court approval and key orders, and the same day filed a combined disclosure statement and joint plan of reorganization that follows the terms of its December 15, 2025 restructuring support agreement, including a planned equity transaction with a future plan sponsor and a framework for distributing any excess sale proceeds, marking a significant step in formalizing its path out of bankruptcy for creditors and other stakeholders.
The most recent analyst rating on (ZYXIQ) stock is a Hold with a $0.13 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXIQ Stock Forecast page.
Spark’s Take on ZYXIQ Stock
According to Spark, TipRanks’ AI Analyst, ZYXIQ is a Underperform.
The score is driven down primarily by deteriorating financial performance (revenue decline, losses, negative equity) and high refinancing/liquidity pressure highlighted on the earnings call. Technicals reinforce the risk with a pronounced downtrend despite oversold readings. Valuation provides limited support because the company is loss-making and has no dividend yield data.
To see Spark’s full report on ZYXIQ stock, click here.
More about Zynex
Zynex, Inc. operates in the medical technology and healthcare sector, providing medical devices and related products through its subsidiaries to patients and healthcare providers in the United States.
Average Trading Volume: 6,036,825
Technical Sentiment Signal: Sell
Current Market Cap: $2.43M
See more data about ZYXIQ stock on TipRanks’ Stock Analysis page.